Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: last shareholder letter

They said 'settlement' - I think it's done.

PTO better get on-the-ball and an indicator of our non-stall will/should be an onslought of new licensees... first Q til april.

e

Share
New Message
Please login to post a reply